Search
for

    Sort by

    Community Join

    990-1000 / 1000+ results

      community DUT Risk profile for having kids?

      in Finasteride/Dutasteride  5 upvotes 3 years ago
      The user has been using a hair loss treatment including oral Minoxidil, topical Minoxidil with Tretinoin and Finasteride, and is considering adding Dutasteride but is concerned about the potential side effects and risks regarding fertility. A reply suggests that having children while on these medications should be fine, advising to avoid letting the partner come into contact with the drugs.

      community Verteporfin (Visudyne) group buy 🌷

      in Treatment  28 upvotes 4 years ago
      User seeks participants for Verteporfin group buy. Verteporfin, FDA approved, may regenerate hair follicles and sweat glands through heavy microneedling.

      community Just got my bloodwork done, should I worry?

      in Finasteride/Dutasteride  10 upvotes 4 years ago
      The conversation discusses concerns about potential side effects, specifically gynecomastia, from taking 1mg of finasteride every other day for hair loss. Bloodwork results were shared, but more information was requested to provide advice.

      community Advice for our Newly Balding Bros.

      in Chat  30 upvotes 6 years ago
      Hair loss advice: stick with treatment, get a good haircut, focus on maintenance, self-care, and accept oneself. Treatments mentioned: Minoxidil, Finasteride, RU58841.

      community Lifestyle choices and your hair....

       6 upvotes 6 years ago
      A person noticed increased hair thinning after changing their workout routine from cycling to weightlifting, which also coincided with a rise in testosterone levels. They are considering stopping intense workouts, switching to yoga, cutting out caffeine, and re-evaluating after a few months to see if it improves their hair condition.

      community Likelihood of new treatments in the next few years?

       8 upvotes 10 years ago
      New hair loss treatments like Shiseido/Replicel and Histogen were discussed, with cautious optimism about their availability by 2018. Setipiprant, Replicel, and Bimatoprost were mentioned as potential treatments expected around 2016-2017.